Co-trimoxazole is a mixture of trimethoprim and sulphamethoxazole in the ratio 1:5.
Routes of administration;
- oral (tablets, suspension and syrup)
- i.m. injection
- i.v. infusion
In clinical practice, changes to the licence indications for the use of co-trimoxazole, apart from pneumocystis carinii, there are few situations in which co-trimoxazole should be prescribed in preference to a single antibiotic.
The summary of product characteristics should be consulted before prescribing this drug.
Last reviewed 01/2018